Psilocybin-Assisted Psychotherapy: Treating Depression and Anxiety with Mushrooms
Sofia Beck
August 5, 2020 DOI: 10.33015/dominican.edu/2020.pas.10 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Topics | Anxiety Psilocybin Depression Psychedelic-assisted therapy |
| Keywords | Depression economics Affect linguistics Mental health Psychotherapist Hallucinogen |
| Citations | 1 |
| Key findings | Current pharmacological treatments for depression and anxiety have limitations, and emerging evidence suggests novel treatment options may shift how these disorders are treated. |
Abstract
Depression and anxiety are debilitating mental health conditions that affect a large portion of the United States. Current pharmacological treatments for these disorders require daily administration, are associated with a number of side effects, and can be ineffective for some. Emerging evidence in novel treatment options may necessitate a shift toward how we treat these psychiatric disorders.
Comparable studies
Other narrative reviews on psilocybin and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development | 2018 | Review | |
| Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. | 2016 | Review | |
| Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy | 2021 | Systematized review | |
| The Emerging Field of Psychedelic Psychotherapy. | 2022 | Review | |
| Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications Participants in psychedelic therapy research aged 18–69 with varied backgrounds | 2020 | Rapid review | n = 180 |